Acid Sphingomyelinase Deficiency (ASMD) Overview

Save information for later
Sign Up

Learn About Acid Sphingomyelinase Deficiency (ASMD)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Acid Sphingomyelinase Deficiency (ASMD) Local Doctors?

No local doctors have been found near Superior, The United States. Expand the search radius or change your location here.

What are the latest Acid Sphingomyelinase Deficiency (ASMD) Clinical Trials?
A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency

Summary: US, multicenter, cohort, open label observational study with primary data collection. Ancillary protocol-specified procedures to address the study objectives (eg, assessment of ADA) may be considered outside the standard of care for acid sphingomyelinase deficiency (ASMD), but the study methodology remains non-interventional, as the additional collection of data from participants will not dictate ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Observational National Pediatric Study on Prevalence of Unexplained Splenomegaly

Objective: To assess prevalence of Gaucher disease (GD) diagnosed in pediatric patients presenting with unexplained splenomegaly (SMG) after exclusion of first intention-diagnoses (e.g. portal hypertension, haematological malignancy, hemolytic anemia, infection) based on clinical examination and routine biological tests (full blood count, reticulocytes, liver tests, abdominal ultrasound, Coombs test and Epst...